ProSci is a leader in antibody development, providing researchers worldwide with innovative tools to push the boundaries of biomedical science.
ProSci LLC is a privately-held biotechnology firm located in San Diego, California. For nearly three decades, we have been at the forefront of antibody development, production, and biological research.
Our expertise is realized through customizable services, innovative products, competitive pricing, high-quality research tools, and unparalleled technical support—all delivered with personalized care.
Connecting science, partners, and people to support discovery and responsible development.
Learn more →Advancing science that serves life through trusted protein solutions and collaborative partnerships.
Learn more →
Specializing in affinity-purified peptide-specific polyclonal antibodies with the same specificity as monoclonal antibodies.
Cancer biomarker discovery and neutralizing antibody development against emergent viruses including SARS-CoV-2, HIV, and influenza.
From antigen design and peptide synthesis to protein conjugation and full antibody development tailored to your needs.
ProSci's innovative research approach using genetically engineered yeast strain and glycoproteins to mimic the HIV-1 glycan coat has been recognized globally.
Our research projects have resulted in an invention patent granted by the U.S. Patent and Trademark Office and numerous peer-reviewed publications.
ProSci supports the responsible and ethical use of animals in order to advance medical science and improve the health of both humans and animals. We recognize animal care is a subject of ethical concern and strive to ensure the humane and responsible treatment of all animals in connection with our research.
We continue to work toward the development of new recombinant antibodies produced via laboratory methods, which reduce the need for animal-derived products while maintaining the highest standards of scientific quality.
Located in the heart of San Diego's biotech hub, our state-of-the-art facility houses cutting-edge research and production capabilities.
